NCT01439958View on ClinicalTrials.gov

Long-term Safety Follow-up Study in the Prevention of Bronchiolitis Obliterans Syndrome (BOS)

PHASE3TerminatedINTERVENTIONAL

Enrollment

14

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

July 31, 2013

Study Completion Date

December 31, 2014

Conditions

Bronchiolitis Obliterans

Interventions

DRUG

Inhalation

Twice daily inhalation for a maximum of three years.

Trial Locations (1)

82166

PARI Pharma GmbH, Gräfelfing

Sponsors

Lead Sponsor

Pari Pharma GmbH

All Listed Sponsors

lead

Pari Pharma GmbH

INDUSTRY

NCT01439958 - Long-term Safety Follow-up Study in the Prevention of Bronchiolitis Obliterans Syndrome (BOS) | Biotech Hunter | Biotech Hunter